Cargando…
Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center
The severity of clinical features and the outcomes in previous series of patients reported with Henoch-Schönlein purpura (HSP) vary greatly, probably due to selection bias. To establish the actual clinical spectrum of HSP in all age groups using an unselected and wide series of patients diagnosed at...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616305/ https://www.ncbi.nlm.nih.gov/pubmed/24646467 http://dx.doi.org/10.1097/MD.0000000000000019 |
_version_ | 1782396602880622592 |
---|---|
author | Calvo-Río, Vanesa Loricera, Javier Mata, Cristina Martín, Luis Ortiz-Sanjuán, Francisco Alvarez, Lino González-Vela, M. Carmen González-Lamuño, Domingo Rueda-Gotor, Javier Fernández-Llaca, Héctor González-López, Marcos A. Armesto, Susana Peiró, Enriqueta Arias, Manuel González-Gay, Miguel A. Blanco, Ricardo |
author_facet | Calvo-Río, Vanesa Loricera, Javier Mata, Cristina Martín, Luis Ortiz-Sanjuán, Francisco Alvarez, Lino González-Vela, M. Carmen González-Lamuño, Domingo Rueda-Gotor, Javier Fernández-Llaca, Héctor González-López, Marcos A. Armesto, Susana Peiró, Enriqueta Arias, Manuel González-Gay, Miguel A. Blanco, Ricardo |
author_sort | Calvo-Río, Vanesa |
collection | PubMed |
description | The severity of clinical features and the outcomes in previous series of patients reported with Henoch-Schönlein purpura (HSP) vary greatly, probably due to selection bias. To establish the actual clinical spectrum of HSP in all age groups using an unselected and wide series of patients diagnosed at a single center, we performed a retrospective review of 417 patients classified as having HSP according to the criteria proposed by Michel et al. Of 417 patients, 240 were male and 177 female, with a median age at the time of disease diagnosis of 7.5 years (interquartile range [IQR], 5.3–20.1 yr). Three-quarters of the patients were children or young people aged 20 years or younger (n = 315), and one-quarter were adults (n = 102). The most frequent precipitating events were a previous infection (38%), usually an upper respiratory tract infection, and/or drug intake (18.5%) shortly before the onset of the vasculitis. At disease onset the most common manifestations were skin lesions (55.9%), nephropathy (24%), gastrointestinal involvement (13.7%), joint symptoms (9.1%), and fever (6.2%). Cutaneous involvement occurring in all patients, mainly purpuric skin lesion, was the most common manifestation when the vasculitis was fully established, followed by gastrointestinal (64.5%), joint (63.1%), and renal involvement (41.2%). The main laboratory findings were leukocytosis (36.7%), anemia (8.9%), and increased serum IgA levels (31.7%). The most frequent therapies used were corticosteroids (35%), nonsteroidal antiinflammatory drugs (14%), and cytotoxic agents (5%). After a median follow-up of 12 months (IQR, 2–38 mo), complete recovery was observed in most cases (n = 346; 83.2%), while persistent, usually mild, nephropathy was observed in only 32 (7.7%) cases. Relapses were observed in almost a third of patients (n = 133; 31.9%). In conclusion, although HSP is a typical vasculitis affecting children and young people, it is not uncommon in adults. The prognosis is favorable in most cases, depending largely on renal involvement. |
format | Online Article Text |
id | pubmed-4616305 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-46163052015-10-27 Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center Calvo-Río, Vanesa Loricera, Javier Mata, Cristina Martín, Luis Ortiz-Sanjuán, Francisco Alvarez, Lino González-Vela, M. Carmen González-Lamuño, Domingo Rueda-Gotor, Javier Fernández-Llaca, Héctor González-López, Marcos A. Armesto, Susana Peiró, Enriqueta Arias, Manuel González-Gay, Miguel A. Blanco, Ricardo Medicine (Baltimore) Original Study The severity of clinical features and the outcomes in previous series of patients reported with Henoch-Schönlein purpura (HSP) vary greatly, probably due to selection bias. To establish the actual clinical spectrum of HSP in all age groups using an unselected and wide series of patients diagnosed at a single center, we performed a retrospective review of 417 patients classified as having HSP according to the criteria proposed by Michel et al. Of 417 patients, 240 were male and 177 female, with a median age at the time of disease diagnosis of 7.5 years (interquartile range [IQR], 5.3–20.1 yr). Three-quarters of the patients were children or young people aged 20 years or younger (n = 315), and one-quarter were adults (n = 102). The most frequent precipitating events were a previous infection (38%), usually an upper respiratory tract infection, and/or drug intake (18.5%) shortly before the onset of the vasculitis. At disease onset the most common manifestations were skin lesions (55.9%), nephropathy (24%), gastrointestinal involvement (13.7%), joint symptoms (9.1%), and fever (6.2%). Cutaneous involvement occurring in all patients, mainly purpuric skin lesion, was the most common manifestation when the vasculitis was fully established, followed by gastrointestinal (64.5%), joint (63.1%), and renal involvement (41.2%). The main laboratory findings were leukocytosis (36.7%), anemia (8.9%), and increased serum IgA levels (31.7%). The most frequent therapies used were corticosteroids (35%), nonsteroidal antiinflammatory drugs (14%), and cytotoxic agents (5%). After a median follow-up of 12 months (IQR, 2–38 mo), complete recovery was observed in most cases (n = 346; 83.2%), while persistent, usually mild, nephropathy was observed in only 32 (7.7%) cases. Relapses were observed in almost a third of patients (n = 133; 31.9%). In conclusion, although HSP is a typical vasculitis affecting children and young people, it is not uncommon in adults. The prognosis is favorable in most cases, depending largely on renal involvement. Lippincott Williams & Wilkins 2014-03-04 /pmc/articles/PMC4616305/ /pubmed/24646467 http://dx.doi.org/10.1097/MD.0000000000000019 Text en Copyright © 2014 by Lippincott Williams & Wilkins |
spellingShingle | Original Study Calvo-Río, Vanesa Loricera, Javier Mata, Cristina Martín, Luis Ortiz-Sanjuán, Francisco Alvarez, Lino González-Vela, M. Carmen González-Lamuño, Domingo Rueda-Gotor, Javier Fernández-Llaca, Héctor González-López, Marcos A. Armesto, Susana Peiró, Enriqueta Arias, Manuel González-Gay, Miguel A. Blanco, Ricardo Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center |
title | Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center |
title_full | Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center |
title_fullStr | Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center |
title_full_unstemmed | Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center |
title_short | Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center |
title_sort | henoch-schönlein purpura in northern spain: clinical spectrum of the disease in 417 patients from a single center |
topic | Original Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616305/ https://www.ncbi.nlm.nih.gov/pubmed/24646467 http://dx.doi.org/10.1097/MD.0000000000000019 |
work_keys_str_mv | AT calvoriovanesa henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter AT loricerajavier henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter AT matacristina henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter AT martinluis henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter AT ortizsanjuanfrancisco henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter AT alvarezlino henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter AT gonzalezvelamcarmen henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter AT gonzalezlamunodomingo henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter AT ruedagotorjavier henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter AT fernandezllacahector henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter AT gonzalezlopezmarcosa henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter AT armestosusana henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter AT peiroenriqueta henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter AT ariasmanuel henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter AT gonzalezgaymiguela henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter AT blancoricardo henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter |